doi: 10.1021/jm00122a027.
Synthesis and structure-activity studies of some disubstituted phenylisoxazoles against human picornavirus
Affiliations
- PMID: 2913305
- DOI: 10.1021/jm00122a027
Item in Clipboard
Synthesis and structure-activity studies of some disubstituted phenylisoxazoles against human picornavirus
J Med Chem.
1989 Feb.
Abstract
A number of 2,6-disubstituted analogues of disoxaril, a broad spectrum antipicornavirus agent, have been prepared and evaluated against several rhinovirus serotypes. A QSAR study revealed that the mean MIC (MIC) against five rhinovirus serotypes correlated well with log P. The 2,6-dichloro analogue, 15, was highly effective in vitro against rhinoviruses with an MIC80 of 0.3 microM, as well as against several enteroviruses, and was also effective in preventing paralysis in mice infected with coxsackievirus A-9.
Similar articles
-
Structure-activity studies of 5-[[4-(4,5-dihydro-2-oxazolyl) phenoxy]alkyl]-3-methylisoxazoles: inhibitors of picornavirus uncoating.J Med Chem. 1987 Feb;30(2):383-8. doi: 10.1021/jm00385a021. J Med Chem. 1987. PMID: 3027340
-
Isoxazoles with antipicornavirus activity.J Med Chem. 1985 Jun;28(6):748-52. doi: 10.1021/jm00383a010. J Med Chem. 1985. PMID: 2989517
-
Antipicornavirus activity of tetrazole analogues related to disoxaril.J Med Chem. 1993 Oct 29;36(22):3240-50. doi: 10.1021/jm00074a004. J Med Chem. 1993. PMID: 8230114
-
Disoxaril-related 3-(diethylamino)-5-phenylisoxazoles.Farmaco. 2000 Feb;55(2):119-24. doi: 10.1016/s0014-827x(00)00002-1. Farmaco. 2000. PMID: 10782382
-
Inhibitors of picornavirus uncoating as antiviral agents.Pharmacol Ther. 1985;29(3):287-97. doi: 10.1016/0163-7258(85)90005-1. Pharmacol Ther. 1985. PMID: 3014575 Review. No abstract available.
Cited by
-
Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.Eur J Med Chem. 2019 Sep 15;178:606-622. doi: 10.1016/j.ejmech.2019.06.008. Epub 2019 Jun 11. Eur J Med Chem. 2019. PMID: 31226653 Free PMC article. Review.
-
The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery.Med Res Rev. 2011 Jan;31(1):42-92. doi: 10.1002/med.20176. Med Res Rev. 2011. PMID: 19714577 Free PMC article. Review.
-
Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection.Antimicrob Agents Chemother. 1993 Feb;37(2):297-300. doi: 10.1128/AAC.37.2.297. Antimicrob Agents Chemother. 1993. PMID: 8383943 Free PMC article. Clinical Trial.
-
Binding affinities of structurally related human rhinovirus capsid-binding compounds are related to their activities against human rhinovirus type 14.Antimicrob Agents Chemother. 1991 Jun;35(6):1040-7. doi: 10.1128/AAC.35.6.1040. Antimicrob Agents Chemother. 1991. PMID: 1656851 Free PMC article.
-
Selective human enterovirus and rhinovirus inhibitors: An overview of capsid-binding and protease-inhibiting molecules.Med Res Rev. 2004 Jul;24(4):449-74. doi: 10.1002/med.10067. Med Res Rev. 2004. PMID: 15170592 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources